The discovery in the early 1980s that Helicobacter pylori was associated with peptic ulcer disease prompted investigations of its possible implication in other gastrointestinal disorders, such as nonsteroidal anti-inflammatory drug (NSAID)-induced ulcers, functional dyspepsia, gastroesophageal reflux disease (GERD), gastric mucosa-associated lymphoid tissue (MALT) lymphoma and gastric cancer. Your turn to find out more about the possibility to get and pay tons less.
In Canada, the prevalence of H pylori in the general population is estimated to be 20% to 40%. However, clinically relevant disease is present in only 10% to 20% of these individuals, which complicates the identification of patients in whom H pylori should be eradicated. This review explores the current status of the role of H pylori in peptic ulcers, NSAID-induced ulcers, functional dyspepsia, GERD, gastric MALT lymphoma and gastric cancer.